LoveReading

Becoming a member of the LoveReading community is free.

No catches, no fine print just unadulterated book loving, with your favourite books saved to your own digital bookshelf.

New members get entered into our monthly draw to win £100 to spend in your local bookshop Plus lots lots more…

Find out more

Medicinal Chemistry of Neglected and Tropical Diseases Synopsis

Medicinal Chemistry of Neglected and Tropical Diseases: Advances in the Design and Synthesis of Antimicrobial Agents consolidates and describes modern drug discovery and development approaches currently employed to identify effective chemotherapeutic agents for the treatment of Neglected Tropical Diseases (NTDs) from a medicinal chemistry perspective. Chapters are designed to cater to the needs of medicinal chemists who work with chemotherapeutic developments for NTDs, as well as serve as a guide to budding medicinal chemists who wish to work in this area. It will introduce rational drug design approaches adopted in designing chemotherapeutics and validated targets available for the purpose.

Book Information

ISBN: 9781138541245
Publication date: 28th August 2019
Author: Venkatesan (Birla Institute of Technology, Dept. of Pharmaceutical Sciences and Technology, India) Jayaprakash
Publisher: CRC Press an imprint of Taylor & Francis Ltd
Format: Hardback
Pagination: 380 pages
Categories: Tropical medicine, Pharmacology, Pharmaceutical technology, Botany & plant sciences,

About Venkatesan (Birla Institute of Technology, Dept. of Pharmaceutical Sciences and Technology, India) Jayaprakash

Dr. Venkatesan Jayaprakash graduated (B. Pharmacy) from Madras Medical College, Madras in Pharmaceutical Sciences. He did his post graduation (M. Pharmacy) in Pharmaceutical Chemistry from Banaras Hindu University, Varanasi. He received his Ph.D. from Birla Institute of Technology, Mesra. Since 2004, he is working as a faculty member in Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra. He is medicinal chemist working in the area of drug design and development against therapeutically validated targets. His current research interest is on developing new chemical entities for the treatment of Tuberculosis (Mycobactin synthetase inhibitors), Viral infections (protease and methyltransferase ...

More About Venkatesan (Birla Institute of Technology, Dept. of Pharmaceutical Sciences and Technology, India) Jayaprakash

Share this book